Catalyst Pharmaceuticals CPRX has reported positive top-line results from an early-stage study evaluating Agamree (vamorolone ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...

Catalyst Pharmaceuticals is fairly valued, with growth reliant on acquired assets Firdapse, Agamree, and Fycompa, but lacks an internal pipeline. CPRX's revenue growth faces headwinds: Firdapse's ...